Source: T3D Therapeutics Blog

T3D Therapeutics Blog Alzheimer’s Association Part The Cloud Grant Program Invests $24 Million in 16 Innovative Research Trials

CHICAGO, AUGUST 25, 2020 — The Clinical trials investigating 16 promising therapies for Alzheimer’s and dementia are taking off thanks to $24 million in new grant funding from the Alzheimer’s Association’s Part the Cloud global research grant program and Bill Gates. Read Full Press Release Here

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
John Didsbury's photo - Chairman & CEO of T3D Therapeutics

Chairman & CEO

John Didsbury

CEO Approval Rating

90/100

Read more